CONAVI MEDICAL CORP (CNVI.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:CNVI - CA2059531020 - Common Stock
CNVI.CA Key Statistics, Chart & Performance
The current stock price of CNVI.CA is 0.45 CAD. In the past month the price decreased by -2.17%. In the past year, price decreased by -40.79%.
CNVI.CA Technical Analysis
CNVI.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CNVI.CA. CNVI.CA may be in some trouble as it scores bad on both profitability and health.
CNVI.CA Financial Highlights
Over the last trailing twelve months CNVI.CA reported a non-GAAP Earnings per Share(EPS) of -0.39. The EPS increased by 58.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -301% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CNVI.CA Forecast & Estimates
5 analysts have analysed CNVI.CA and the average price target is 1.02 CAD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 0.45.
For the next year, analysts expect an EPS growth of 50% and a revenue growth -34.34% for CNVI.CA
CNVI.CA Ownership
About CNVI.CA
Company Profile
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
Company Info
CONAVI MEDICAL CORP
76 Berkeley Street
TORONTO ONTARIO CA
Employees: 4
Phone: 14165487522
CONAVI MEDICAL CORP / CNVI.CA FAQ
What does CNVI do?
Conavi Medical Corp. engages in the designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The company is headquartered in Toronto, Ontario and currently employs 4 full-time employees. The company went IPO on 2008-04-28. The firm is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary interventions (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.
What is the stock price of CONAVI MEDICAL CORP today?
The current stock price of CNVI.CA is 0.45 CAD. The price increased by 1.12% in the last trading session.
Does CONAVI MEDICAL CORP pay dividends?
CNVI.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of CNVI stock?
CNVI.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about CONAVI MEDICAL CORP (CNVI.CA) stock?
5 analysts have analysed CNVI.CA and the average price target is 1.02 CAD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 0.45.
Can you provide the upcoming earnings date for CONAVI MEDICAL CORP?
CONAVI MEDICAL CORP (CNVI.CA) will report earnings on 2026-03-01.